Esperion Therapeutics Stock Market Value
| ESPR Stock | USD 3.55 0.12 3.50% |
| Symbol | Esperion |
Can Biotechnology industry sustain growth momentum? Does Esperion have expansion opportunities? Factors like these will boost the valuation of Esperion Therapeutics. Projected growth potential of Esperion fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Esperion Therapeutics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.54) | Revenue Per Share | Quarterly Revenue Growth 0.691 | Return On Assets | Return On Equity |
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Esperion Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Esperion Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Esperion Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Esperion Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Esperion Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Esperion Therapeutics.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Esperion Therapeutics on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Esperion Therapeutics or generate 0.0% return on investment in Esperion Therapeutics over 90 days. Esperion Therapeutics is related to or competes with SNDL, SIGA Technologies, Aquestive Therapeutics, Emergent Biosolutions, Ventyx Biosciences, Corvus Pharmaceuticals, and Olema Pharmaceuticals. Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patien... More
Esperion Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Esperion Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Esperion Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.93 | |||
| Information Ratio | 0.0566 | |||
| Maximum Drawdown | 24.91 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 6.53 |
Esperion Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Esperion Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Esperion Therapeutics' standard deviation. In reality, there are many statistical measures that can use Esperion Therapeutics historical prices to predict the future Esperion Therapeutics' volatility.| Risk Adjusted Performance | 0.0631 | |||
| Jensen Alpha | 0.1591 | |||
| Total Risk Alpha | 0.0534 | |||
| Sortino Ratio | 0.0606 | |||
| Treynor Ratio | 0.099 |
Esperion Therapeutics February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0631 | |||
| Market Risk Adjusted Performance | 0.109 | |||
| Mean Deviation | 3.27 | |||
| Semi Deviation | 3.59 | |||
| Downside Deviation | 3.93 | |||
| Coefficient Of Variation | 1445.48 | |||
| Standard Deviation | 4.21 | |||
| Variance | 17.75 | |||
| Information Ratio | 0.0566 | |||
| Jensen Alpha | 0.1591 | |||
| Total Risk Alpha | 0.0534 | |||
| Sortino Ratio | 0.0606 | |||
| Treynor Ratio | 0.099 | |||
| Maximum Drawdown | 24.91 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 6.53 | |||
| Downside Variance | 15.46 | |||
| Semi Variance | 12.9 | |||
| Expected Short fall | (3.37) | |||
| Skewness | 0.6681 | |||
| Kurtosis | 2.1 |
Esperion Therapeutics Backtested Returns
Esperion Therapeutics appears to be unstable, given 3 months investment horizon. Esperion Therapeutics secures Sharpe Ratio (or Efficiency) of 0.11, which denotes the company had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Esperion Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Esperion Therapeutics' Downside Deviation of 3.93, coefficient of variation of 1445.48, and Mean Deviation of 3.27 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Esperion Therapeutics holds a performance score of 8. The firm shows a Beta (market volatility) of 2.84, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Esperion Therapeutics will likely underperform. Please check Esperion Therapeutics' value at risk, as well as the relationship between the kurtosis and price action indicator , to make a quick decision on whether Esperion Therapeutics' price patterns will revert.
Auto-correlation | -0.58 |
Good reverse predictability
Esperion Therapeutics has good reverse predictability. Overlapping area represents the amount of predictability between Esperion Therapeutics time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Esperion Therapeutics price movement. The serial correlation of -0.58 indicates that roughly 58.0% of current Esperion Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.58 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Pair Trading with Esperion Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Esperion Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Esperion Stock
| 0.59 | H2K2 | XTL Biopharmaceuticals Split | PairCorr |
| 0.55 | ABNX | Abionyx Pharma SA | PairCorr |
| 0.5 | AVH | Avita Medical | PairCorr |
| 0.42 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.4 | OB3 | OPTIBIOTIX HLTH PLC | PairCorr |
The ability to find closely correlated positions to Esperion Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Esperion Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Esperion Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Esperion Therapeutics to buy it.
The correlation of Esperion Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Esperion Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Esperion Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Esperion Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.